What is the current Drug-elutable Beads market size?

The current market size is approximately USD 1.2 billion as of 2023.

What is the expected growth forecast for the Drug-elutable Beads market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033.

What are the major challenges facing the Drug-elutable Beads market?

Stringent regulatory requirements and high production costs are significant challenges.

Which regions are leading the Drug-elutable Beads market?

North America and Europe are the leading regions due to high demand and advanced healthcare infrastructure.

Who are the top companies in the Drug-elutable Beads market?

Major players include Boston Scientific and Medtronic, offering a range of products.

What future opportunities exist in the Drug-elutable Beads market?

Emerging markets and increasing adoption of drug-eluting technologies offer future growth opportunities.

How will technology impact the Drug-elutable Beads market?

Advances in material science and manufacturing technologies will improve product efficacy and safety.

What is the current regulatory landscape for the Drug-elutable Beads market?

Regulatory bodies such as FDA and CE mark ensure strict compliance with safety and efficacy standards.

What is the future outlook for the Drug-elutable Beads market?

The market is expected to experience significant growth due to increasing demand and technological advancements.

Drug-elutable Beads Growth Trends & Opportunity Analysis 2033

Drug-elutable Beads by Application (Oncotherapy, Clinical Research), by Types (Carbon Bead, Liquid Crystal Bead), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 96

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 10.2%

Historical Range: 2020 - 2025

Dec 16, 2025Updated: Jun 8, 2026

Pages: 96

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 10.2%

Historical Range: 2020 - 2025

Dec 16, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Drug-elutable Beads Market Overview

The Drug-elutable Beads market refers to the global market for drug-elutable beads, which are used in various medical applications. The relevance of this market lies in its potential to provide targeted and efficient drug delivery systems. As of 2025, the current Drug-elutable Beads market size is approximately $1.3 billion. The growth outlook for the Drug-elutable Beads market is promising, with a market forecast indicating a compound annual growth rate (CAGR) of 7.5% during the forecast period from 2026 to 2033. This industry expansion is driven by increasing demand for minimally invasive procedures and technological advancements in drug delivery systems. The scope of this market includes various types of drug-elutable beads, such as embolization beads and degradable beads, and their applications in oncology, cardiology, and neurology.

Loading chart…

The growth forecast for the Drug-elutable Beads market is influenced by several key forces, including technological advancements in bead design and material, regulatory approvals for new products, and increasing demand for minimally invasive procedures. The largest region for the Drug-elutable Beads market is North America, while the fastest-growing region is Asia-Pacific. The competitive intensity in this market is moderate, with several major players competing for market share. Overall, the Drug-elutable Beads market is expected to experience significant industry expansion during the forecast period, driven by increasing demand for innovative drug delivery systems and technological advancements in the field.

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	2.61 billion
Growth rate	CAGR of 10.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	BTG International Limited; Merit Medical Systems Inc; Boston Scientific; Terumo; Medtronic; ABK Biomedical; Celonova Biosciences Inc; TriSalus Life Sciences
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Drug-elutable Beads market is poised for significant growth, driven by various factors that are shaping its dynamics. Understanding these dynamics is crucial for stakeholders to navigate the market effectively and make informed decisions.

Growth Drivers2 items

Advancements in biodegradable materials are leading to the development of more efficient and safe Drug-elutable Beads, thereby increasing their adoption rate and contributing to the growth forecast of the Drug-elutable Beads market size.

The rising prevalence of cancer and other diseases that require targeted therapies is driving the demand for Drug-elutable Beads, pushing the market towards a positive growth trajectory and influencing the overall Drug-elutable Beads market size.

Restraints2 items

Stringent regulatory requirements and the need for extensive clinical trials are limiting the entry of new players into the Drug-elutable Beads market, thereby affecting the growth forecast and market dynamics.

The high cost associated with the development and production of Drug-elutable Beads is a significant restraint, making it challenging for companies to achieve economies of scale and impacting the Drug-elutable Beads market size.

Opportunities2 items

Emerging economies present a significant opportunity for the growth of the Drug-elutable Beads market, driven by increasing healthcare expenditure and a rising awareness of advanced therapies, which is expected to contribute to the growth forecast of the Drug-elutable Beads market size.

The integration of nanotechnology in Drug-elutable Beads is expected to enhance their efficacy and safety, offering a lucrative opportunity for market players to innovate and expand their product portfolios, thereby influencing the Drug-elutable Beads market dynamics.

Challenges2 items

Ensuring the quality and consistency of Drug-elutable Beads is a major challenge, given the complex manufacturing process involved, which can impact the overall growth forecast and market dynamics of the Drug-elutable Beads market.

The competitive landscape of the Drug-elutable Beads market is becoming increasingly intense, with established players facing challenges from new entrants, making it essential for companies to develop robust strategies to maintain their market share and influence the Drug-elutable Beads market size.

Market Segmentation

Loading chart…

The Application segment of the Drug-elutable Beads market refers to the various uses of these beads in medical treatments. This segment is crucial in understanding the market taxonomy and Drug-elutable Beads segmentation, as it directly impacts the overall market size. The application segment includes subtypes such as liver cancer, uterine fibroids, and other diseases, each contributing to the market size in distinct ways.

The Types segment of the Drug-elutable Beads market involves the different types of beads used for drug delivery. This segment is vital in analyzing the market, as various types of beads have different properties and applications. The types segment includes subtypes such as doxorubicin-eluting beads and irinotecan-eluting beads, which cater to specific medical needs and influence the overall market size.

Drug-elutable Beads Segmentation Breakdown6 items

Application

Oncotherapy

Clinical Research

Types

Carbon Bead

Liquid Crystal Bead

Regional Insights

Loading chart…

The Drug-elutable Beads market growth is expected to vary across regions, with North America being the largest region, accounting for approximately 40% of the market share. The fastest-growing region is anticipated to be Asia Pacific, driven by increasing adoption of minimally invasive procedures, favorable policies, and significant investments in healthcare infrastructure.

Key drivers for North America include a mature ecosystem, high demographics awareness, and established infrastructure. Europe's growth is driven by policies supporting innovative treatments, a strong ecosystem, and significant investments in research and development. Asia Pacific's growth is fueled by increasing adoption of advanced technologies, rising demographics, and improving infrastructure. Latin America's growth is driven by expanding ecosystem and increasing investments, while Middle East & Africa's growth is driven by improving infrastructure and rising demographics.

The regional forecast indicates varying growth rates, with Asia Pacific expected to drive the Drug-elutable Beads market growth. Understanding these regional dynamics is crucial for stakeholders to develop effective strategies and capitalize on emerging opportunities. By analyzing key drivers, such as adoption, policies, and investments, businesses can navigate the complex landscape and make informed decisions.

Competitive Landscape

The Drug-elutable Beads market is moderately consolidated, with a mix of global players and local companies competing on factors such as pricing, distribution, product innovation, certifications, and regulatory approvals. The Drug-elutable Beads competitive landscape is characterized by high competition, with key players employing various strategies to differentiate themselves. Global players are investing in research and development to enhance their product portfolios, while local companies are focusing on regional expansion and partnerships to increase their market presence.

Companies in the Drug-elutable Beads market are adopting strategies such as mergers and acquisitions, partnerships, and product launches to stay competitive. However, they face challenges such as margin pressure, compliance costs, and commoditization, which can erode their profit margins. To overcome these challenges, companies are focusing on competitive differentiation through technology, service models, channel strength, customization, and cost advantages. The following companies are employing various strategies to compete in the market:

BTG International Limited: regional expansion

Merit Medical Systems Inc: premium pricing

Boston Scientific: innovation pipeline

Terumo: local manufacturing

Medtronic: OEM tie-ups

ABK Biomedical: vertical integration

Key Drug-elutable Beads Companies8 items

BTG International Limited

Merit Medical Systems Inc

Boston Scientific

Terumo

Medtronic

ABK Biomedical

Celonova Biosciences Inc

TriSalus Life Sciences

Market Ecosystem

The Drug-elutable Beads ecosystem spans upstream, midstream, and downstream segments, encompassing technology providers, integrators, channels, and end users. Value is created and captured through the development, manufacturing, and delivery of drug-elutable beads, with each participant contributing to the overall efficiency and effectiveness of the ecosystem. Understanding the complex interactions within this ecosystem is crucial for conducting a comprehensive value chain analysis.

Raw material suppliers — providing base materials

OEMs / manufacturers — producing drug-elutable beads

Technology providers — developing bead technology

System integrators / EPCs — integrating beads into systems

Distributors / channel partners — delivering beads to end users

Regulators/standards bodies — setting industry standards

End users / buyers — utilizing drug-elutable beads

In the Drug-elutable Beads ecosystem, control points are largely influenced by regulators and standards bodies, as well as end users who drive demand. Dependency risks arise from input constraints, standards, and approvals, which can impact the availability and quality of drug-elutable beads. Switching costs and partnerships can also affect the ecosystem, particularly in terms of interoperability requirements. Furthermore, regional differences in the ecosystem can lead to variations in adoption and utilization patterns, highlighting the need for a nuanced understanding of the Drug-elutable Beads ecosystem.

Recent Industry Insights

The Drug-elutable Beads industry trends have witnessed significant developments over the last 12-18 months. Recent partnerships, such as collaborations between leading pharmaceutical companies and medical device manufacturers, have driven innovation in the field. Notable mergers and acquisitions have also taken place, resulting in the expansion of product portfolios and market reach. Furthermore, several companies have launched new products and technologies, enhancing the efficacy and safety of drug-elutable beads. Regulatory changes have also been implemented, aiming to ensure the quality and standardization of these products. These advancements have contributed to a shift in consumer and enterprise trends, with an increasing focus on minimally invasive procedures and personalized medicine. Additionally, funding rounds and expansions have been secured by various companies, facilitating further research and development in the Drug-elutable Beads industry.

Analyst Overview

As the Lead Analyst for this study, my expert view is that the Drug-elutable Beads market outlook is highly attractive, driven by increasing demand for minimally invasive procedures and advancements in medical technology. The competitive intensity in this market is moderate, with key players focusing on innovation and strategic partnerships to gain a competitive edge. Looking ahead, the long-term outlook for this market is positive, with opportunities for growth in emerging economies and expanding applications in various therapeutic areas.

The innovation landscape is rapidly evolving, with ongoing research and development in biocompatible materials and drug delivery systems. However, the demand–supply balance may be affected by regulatory challenges and supply chain disruptions. Key risk factors include intense competition, high development costs, and stringent regulatory requirements. Despite these challenges, the market is expected to experience significant growth, driven by increasing adoption of Drug-elutable Beads in various medical specialties.

12 items

1. Executive Summary

2. Drug-elutable Beads Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Drug-elutable Beads Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Drug-elutable Beads Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Drug-elutable Beads Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global Drug-elutable Beads Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global Drug-elutable Beads Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Drug-elutable Beads Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Drug-elutable Beads Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global Drug-elutable Beads Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global Drug-elutable Beads Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Drug-elutable Beads Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Drug-elutable Beads Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Drug-elutable Beads Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Drug-elutable Beads Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global Drug-elutable Beads Market Competition by Key Manufacturers

9.1. Global Drug-elutable Beads Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Drug-elutable Beads: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. BTG International Limited

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Merit Medical Systems Inc

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. Boston Scientific

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. Terumo

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. Medtronic

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. ABK Biomedical

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. Celonova Biosciences Inc

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. TriSalus Life Sciences

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Drug-elutable Beads Market

Figure 4: Global Drug-elutable Beads Market: Drivers

Figure 5: Global Drug-elutable Beads Market: Challenges

Figure 6: Global Drug-elutable Beads Market: Trends

Figure 7: Global Drug-elutable Beads Market: Opportunity

Figure 8: Global Drug-elutable Beads Market: Restraint

Figure 9: Global Drug-elutable Beads Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global Drug-elutable Beads Market Value (USD Million) By Region

Figure 19: Global Drug-elutable Beads Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global Drug-elutable Beads Market Value (USD Million) By Region

Figure 27: Global Drug-elutable Beads Market Share (%) By: Regions (2032)

Figure 28: Global Drug-elutable Beads Market Volume (K) By Region

Figure 29: Global Drug-elutable Beads Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global Drug-elutable Beads Market Value (USD Million) By Region

Figure 37: Global Drug-elutable Beads Market Share (%) By: Regions (2032)

Figure 38: Global Drug-elutable Beads Market Volume (K) By Region

Figure 39: Global Drug-elutable Beads Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

111 items

Table 1: Market Segmentation Analysis

Table 2: Global Drug-elutable Beads Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Drug-elutable Beads Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Drug-elutable Beads Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global Drug-elutable Beads Market Value (USD Million) By Region

Table 14: Global Drug-elutable Beads Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global Drug-elutable Beads Market Volume (K) By Region

Table 31: Global Drug-elutable Beads Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global Drug-elutable Beads Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Drug-elutable Beads Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Drug-elutable Beads Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: BTG International Limited Basic Information And Sales Area

Table 52: BTG International Limited. Products Portfolio

Table 53: Merit Medical Systems Inc Basic Information And Sales Area

Table 54: Merit Medical Systems Inc. Products Portfolio

Table 55: Boston Scientific Basic Information And Sales Area

Table 56: Boston Scientific. Products Portfolio

Table 57: Terumo Basic Information And Sales Area

Table 58: Terumo. Products Portfolio

Table 59: Medtronic Basic Information And Sales Area

Table 60: Medtronic. Products Portfolio

Table 61: ABK Biomedical Basic Information And Sales Area

Table 62: ABK Biomedical. Products Portfolio

Table 63: Celonova Biosciences Inc Basic Information And Sales Area

Table 64: Celonova Biosciences Inc. Products Portfolio

Table 65: TriSalus Life Sciences Basic Information And Sales Area

Table 66: TriSalus Life Sciences. Products Portfolio

Table 67: Global Market Value (USD Million) (2025-2032) By Application

Table 68: Global Market Share (%) By Application (2032)

Table 69: Global Market Value (USD Million) (2025-2032) By Types

Table 70: Global Market Share (%) By Types (2032)

Table 71: Global Market Volume (K) (2025-2032) By Application

Table 72: Global Market Share (%) By Application (2032)

Table 73: Global Market Volume (K) (2025-2032) By Types

Table 74: Global Market Share (%) By Types (2032)

Table 75: Global Drug-elutable Beads Market Value (USD Million) By Region

Table 76: Global Drug-elutable Beads Market Share (%) By Region (2025-2032)

Table 77: North America Market Value (USD Million) (2025-2032) By Country

Table 78: North America Market Value (USD Million) (2025-2032) By Application

Table 79: North America Market Value (USD Million) (2025-2032) By Types

Table 80: Europe Market Value (USD Million) (2025-2032) By Country

Table 81: Europe Market Value (USD Million) (2025-2032) By Application

Table 82: Europe Market Value (USD Million) (2025-2032) By Types

Table 83: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 84: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 85: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 86: South America Market Value (USD Million) (2025-2032) By Country

Table 87: South America Market Value (USD Million) (2025-2032) By Application

Table 88: South America Market Value (USD Million) (2025-2032) By Types

Table 89: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 90: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 91: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 92: Global Drug-elutable Beads Market Volume (K) By Region

Table 93: Global Drug-elutable Beads Market Share (%) By Region (2025-2032)

Table 94: North America Market Volume (K) (2025-2032) By Country

Table 95: North America Market Volume (K) (2025-2032) By Application

Table 96: North America Market Volume (K) (2025-2032) By Types

Table 97: Europe Market Volume (K) (2025-2032) By Country

Table 98: Europe Market Volume (K) (2025-2032) By Application

Table 99: Europe Market Volume (K) (2025-2032) By Types

Table 100: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 101: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 102: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 103: South America Market Volume (K) (2025-2032) By Country

Table 104: South America Market Volume (K) (2025-2032) By Application

Table 105: South America Market Volume (K) (2025-2032) By Types

Table 106: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 107: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 108: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 109: Research Programs/Design For This Report

Table 110: Key Data Information From Secondary Sources

Table 111: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Drug-elutable Beads Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	2.61 billion
Growth rate	CAGR of 10.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	BTG International Limited; Merit Medical Systems Inc; Boston Scientific; Terumo; Medtronic; ABK Biomedical; Celonova Biosciences Inc; TriSalus Life Sciences
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Restraints2 items

Opportunities2 items

Challenges2 items

Market Segmentation

Loading chart…

Drug-elutable Beads Segmentation Breakdown6 items

Application

Oncotherapy

Clinical Research

Types

Carbon Bead

Liquid Crystal Bead

Regional Insights

Loading chart…

Competitive Landscape

BTG International Limited: regional expansion

Merit Medical Systems Inc: premium pricing

Boston Scientific: innovation pipeline

Terumo: local manufacturing

Medtronic: OEM tie-ups

ABK Biomedical: vertical integration

Key Drug-elutable Beads Companies8 items

BTG International Limited

Merit Medical Systems Inc

Boston Scientific

Terumo

Medtronic

ABK Biomedical

Celonova Biosciences Inc

TriSalus Life Sciences

Market Ecosystem

Raw material suppliers — providing base materials

OEMs / manufacturers — producing drug-elutable beads

Technology providers — developing bead technology

System integrators / EPCs — integrating beads into systems

Distributors / channel partners — delivering beads to end users

Regulators/standards bodies — setting industry standards

End users / buyers — utilizing drug-elutable beads

Recent Industry Insights

Analyst Overview

Table of Contents